| P2093 | author name string | Pil Soo Sung | |
| | Seung Kew Yoon | |
| | Jong Young Choi | |
| | Jeong Won Jang | |
| | Eun Byul Lee | |
| | Angelo Lozada | |
| | Dong Jun Park | |
| | Si Hyun Bae | |
| P2860 | cites work | Interferon-induced gene expression is a stronger predictor of treatment response than IL28B genotype in patients with hepatitis C. | Q50558076 |
| | KASL clinical practice guidelines: management of hepatitis C | Q26752471 |
| | Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection | Q26784252 |
| | Regulation of hepatic innate immunity by hepatitis C virus | Q26824743 |
| | Immune responses to HCV and other hepatitis viruses | Q26866955 |
| | Stealth and cunning: hepatitis B and hepatitis C viruses | Q27470232 |
| | Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 |
| | Interferon signaling and treatment outcome in chronic hepatitis C | Q27486083 |
| | Interferons at age 50: past, current and future impact on biomedicine | Q28259312 |
| | Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase | Q28291219 |
| | Global epidemiology and burden of HCV infection and HCV-related disease | Q30240220 |
| | Characterization of miR-122-independent propagation of HCV. | Q33719172 |
| | IFN-λ4 potently blocks IFN-α signalling by ISG15 and USP18 in hepatitis C virus infection. | Q33812521 |
| | Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome | Q33944295 |
| | Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells | Q34059207 |
| | Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. | Q35091008 |
| | New insights into type I interferon and the immunopathogenesis of persistent viral infections | Q35648751 |
| | Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness. | Q35989977 |
| | Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin | Q37062210 |
| | Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver | Q37684887 |
| | The JAK-STAT pathway at twenty | Q38004201 |
| | Immune responses and immunopathology in acute and chronic viral hepatitis | Q38885002 |
| | Reversion of disease manifestations after HCV eradication | Q38958207 |
| | Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection | Q39144671 |
| | Type I Interferon in Chronic Virus Infection and Cancer. | Q39349338 |
| | Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir | Q39687020 |
| | CXCL10 is produced in hepatitis A virus-infected cells in an IRF3-dependent but IFN-independent manner. | Q40108522 |
| | Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals | Q40206472 |
| | "Hep C, where art thou": What are the remaining (fundable) questions in hepatitis C virus research? | Q40536482 |
| | Activation of human natural killer cells by the soluble form of cellular prion protein. | Q41115671 |
| | Evidence for immune activation in patients with residual hepatitis C virus RNA long after successful treatment with IFN and ribavirin. | Q42210883 |
| | Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis | Q42251872 |
| | Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients. | Q47573949 |
| | Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C. | Q47707529 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 3 | |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 302-310 | |
| P577 | publication date | 2018-03-12 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Interferon-free treatment for hepatitis C virus infection induces normalization of extrahepatic type I interferon signaling | |
| P478 | volume | 24 | |